PT-141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide and melanocortin receptor agonist. It is supplied as a high-purity lyophilized peptide for qualified laboratory research, analytical development and manufacturing applications.
Product Specifications
Product Name: PT-141 (Bremelanotide)
Synonyms:Bremelanotide, PT-141, PT141, melanocortin receptor agonist
CAS Number: 189691-06-3
Molecular Formula: C50H68N14O10
Molecular Weight: 1025.16 g/mol
Purity: ≥98% by HPLC
Form: Lyophilized powder
Storage: Store at -20°C, dry and protected from light
Available Sizes: 5 mg/10vial and 10 mg/10vial
Documentation: COA, HPLC and MS data available by batch
Quality & Documentation
Each production batch can be supported with analytical documentation including Certificate of Analysis (COA), HPLC purity testing and mass spectrometry identity data according to the agreed product specification.
Packaging & OEM/ODM
Standard vial packaging and bulk peptide specifications are available for laboratory and manufacturing customers. Custom packaging, labeling and OEM/ODM requirements can be discussed according to project requirements and applicable regulations.
Research Use Notice
For research and manufacturing use only. Supplied to qualified businesses and laboratories in accordance with applicable destination-country regulations. Not intended for personal, diagnostic or therapeutic use unless separately registered and authorized for such use.
